Significant increase of high-density lipoprotein2-cholesterol under prolonged simvastatin treatment (Q67856221)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1789812%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Significant increase of high-density lipoprotein2-cholesterol under prolonged simvastatin treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1789812%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1789812

Cardiology and cardiovascular medicine

26 November 2022

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

26 November 2022

author name string

M. P. Neuman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1789812

26 November 2022

H. R. Neuman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1789812

26 November 2022

J. Neuman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1789812

26 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1789812

26 November 2022

publication date

1 December 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1789812%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://api.elsevier.com/content/article/PII:002191509190202E?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

https://api.elsevier.com/content/article/PII:002191509190202E?httpAccept=text/plain

26 November 2022

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

26 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1789812%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

91 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1789812%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

S11-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1789812%20AND%20SRC:MED&resulttype=core&format=json

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

18 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

26 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study

26 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial

26 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

26 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Relation of high-density lipoproteins to coronary artery disease

26 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

26 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

High-density lipoprotein subfractions in normolipidemic patients with coronary atherosclerosis

26 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

HDL2 and HDL3 lipid levels in coronary artery disease

26 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism

26 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia

26 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia

26 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Synvinolin in hypercholesterolaemia

26 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study

26 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia

26 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

26 November 2022

Electroimmuno assay

21

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic

26 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Liver lipase and high-density lipoprotein. Lipoprotein changes after incubation of human serum with rat liver lipase

26 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Characterization of a human hepatic receptor for high density lipoproteins.

26 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity

26 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Elevation of high density lipoprotein cholesterol (cHDL) and reduction of the total cholesterol/cHDL index in the treatment of hyperlipoproteinaemias IIb and IV with bezafibrate

26 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Nonpharmacologic and pharmacologic alteration of high-density lipoprotein cholesterol: therapeutic approaches to prevention of atherosclerosis

26 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

Comparison of six pharmacologic regimens for hypercholesterolemia

26 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0021-9150(91)90202-E

26 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1789812%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference